Evaluation of Resection Techniques for Pancreatic Tumors
Launched by METHODIST HEALTH SYSTEM · Nov 9, 2021
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different surgical methods for removing tumors from the pancreas and liver. The researchers want to see how these methods—open surgery versus minimally invasive surgery—affect important factors like patient survival, hospital stay duration, complication rates, and overall costs. By comparing these techniques, the study aims to find out which approach might be better for patients.
To be eligible for this trial, you need to be at least 18 years old and have had surgery to remove a pancreatic or liver tumor at Methodist Dallas Medical Center between January 2006 and December 2020. If you’re chosen to participate, you can expect to provide information about your health and recovery after surgery. The trial is currently recruiting participants, so if you or someone you know fits the criteria, this could be a valuable opportunity to contribute to important medical research.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients that have undergone pancreatic or liver resection surgeries from January 2006 until December 2020 at Methodist Dallas Medical Center (MDMC)
- • Patients 18 years old or older
- Exclusion Criteria:
- • Patients that have not undergone pancreatic resection surgeries
- • Patients under 18 years of age
About Methodist Health System
Methodist Health System is a leading healthcare provider dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care and scientific inquiry, the organization leverages its state-of-the-art facilities and multidisciplinary expertise to conduct rigorous studies across various therapeutic areas. Methodist Health System collaborates with healthcare professionals, researchers, and industry partners to enhance the understanding of diseases and develop new treatment modalities, ensuring that cutting-edge therapies are accessible to the communities it serves. Through its clinical trial initiatives, Methodist Health System aims to contribute to the evolving landscape of medicine while prioritizing patient safety and ethical standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dallas, Texas, United States
Patients applied
Trial Officials
Alejandro Mejia, M.D.
Principal Investigator
The Liver Institute, Methodist Dallas Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials